Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model.

MLA

Sung, Bokyung, et al. “Curcumin Circumvents Chemoresistance in Vitro and Potentiates the Effect of Thalidomide and Bortezomib against Human Multiple Myeloma in Nude Mice Model.” Molecular Cancer Therapeutics, vol. 8, no. 4, Apr. 2009, pp. 959–70. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-08-0905.

APA

Sung, B., Kunnumakkara, A. B., Sethi, G., Anand, P., Guha, S., & Aggarwal, B. B. (2009). Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Molecular Cancer Therapeutics, 8(4), 959–970. https://doi.org/10.1158/1535-7163.MCT-08-0905

Chicago

Sung, Bokyung, Ajaikumar B Kunnumakkara, Gautam Sethi, Preetha Anand, Sushovan Guha, and Bharat B Aggarwal. 2009. “Curcumin Circumvents Chemoresistance in Vitro and Potentiates the Effect of Thalidomide and Bortezomib against Human Multiple Myeloma in Nude Mice Model.” Molecular Cancer Therapeutics 8 (4): 959–70. doi:10.1158/1535-7163.MCT-08-0905.